Results 21 to 30 of about 14,058 (159)

β3‐Adrenoceptor Agonists for Neurogenic Lower Urinary Tract Dysfunction: Evidence and Clinical Rationale for First‐Line Therapy

Neurourology and Urodynamics, EarlyView.
ABSTRACT Aims To summarize current evidence on β3‐adrenoceptor agonists for managing neurogenic lower urinary tract dysfunction (NLUTD), focusing on their efficacy, safety, and clinical role in optimizing bladder storage and protecting upper tracts. Methods Evidence from randomized controlled trials, meta‐analyses, and observational studies in spinal ...
Sharon E. Fishberg, Rano Matta
wiley   +1 more source

Barriers to early and effective overactive bladder management in male patients with lower urinary tract symptoms.

PLoS ONE
Overactive bladder is underdiagnosed and undertreated in men as symptoms overlap with benign prostatic obstruction. This study identified barriers urologists encountered in effectively managing overactive bladder in men with lower urinary tract symptoms.
Paul Rasner, Maria Arcila-Ruiz, José Ailton Fernandes Silva, Umaphorn Nuanthaisong, Sung Yung Cho, Eric Chung   +5 more
doaj   +1 more source

Patterns of activation of vanilloid and purinergic receptors of the bladder urothelium in elderly with hyperfunction of urothelium, atherosclerosis and their combination

Клиническая практика, 2018
This article describes the patterns of activation of vanilloid and purinergic receptors in the bladder tissue in males of different ages. Based on the obtained data, the conclusions are made about the prospects of using activation of these receptors as ...
K. I. Prashchaev, A. N. Ilnitski, A. A. Pranovich, G. I. Gurko, A. N. Selivanov   +4 more
doaj   +1 more source

Impact of COVID‐19 and Vaccination on Lower Urinary Tract Symptoms: Insights From a Prospective Cohort Study

Neurourology and Urodynamics, EarlyView.
ABSTRACT Aims To evaluate the prevalence, clinical course, and risk factors of lower urinary tract symptoms (LUTS) in patients hospitalized with COVID‐19, and to assess associations with comorbidities, disease severity, and vaccination status. Methods We conducted a prospective cohort study of adult patients hospitalized with confirmed COVID‐19, who ...
Julia Duarte de Souza, Jose de Bessa Jr., Natássia Cristina Carboni Truzzi, Carolina Trigo Rocha, Bruno Camargo Rocha Paim de Araujo, Julyana Kanate Mazzoni Moromizato, Thulio Bosi Vieira Brandão, Rachel Mazoni Costa, Marcelo Hisano, Zein Mohamed Sammour, Homero Bruschini, William Carlos Nahas, Cristiano Mendes Gomes   +12 more
wiley   +1 more source

Bladder and urodynamic changes in multiple sclerosis

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2020
Background Urinary dysfunction is a common symptom during the course of multiple sclerosis (MS). Long-term follow-up of the natural history of bladder dysfunction in MS has been seldom addressed.
Hesham Torad, Nevin Shalaby, Hussein Aly Hussein, Samih Z. Sadek, Mohamed S. Abdelazim, Ahmed Yehia, Samer Morsy, Shaimaa H. Soliman   +7 more
doaj   +1 more source

Retropubic versus transobturator slings: Medium-term satisfaction and overactive bladder outcomes. [PDF]

Int J Gynaecol Obstet
Abstract Objective This study compares medium‐term outcomes of retropubic tension‐free vaginal tape (TVT) and transobturator tape (TOT) for stress urinary incontinence (SUI), focusing on patient satisfaction and overactive bladder (OAB) symptoms. Methods This prospective, single‐surgeon cohort study included women with SUI who underwent TVT or TOT at a
Gandelsman E, Neuman J, Fábián-Kovács R, Friedman T, Neuman M, Feiner B.   +5 more
europepmc   +2 more sources

“What Medical Management Should Be First Line for Bladder Storage Symptoms in NLUTD”—Pro Botox

Neurourology and Urodynamics, EarlyView.
ABSTRACT Objectives Neurogenic lower urinary tract dysfunction (NLUTD) severely impairs patient quality of life (QoL). While oral medications are often first‐line treatments, their high failure rates and side effects limit their effectiveness. Thus, we argue for the use of intravesical botulinum toxin A (BoNT‐A) injections as a first‐line alternative ...
Vada Furlan, Alyssa Kobayashi, Zhina Sadeghi   +2 more
wiley   +1 more source

Utility of Pelvic Floor Therapy and Behavioral Interventions in the Neurogenic Lower Urinary Tract Dysfunction (NLUTD) Population

Neurourology and Urodynamics, EarlyView.
ABSTRACT Aims Neurogenic lower urinary tract dysfunction (NLUTD) describes a wide range of symptoms depending on neurologic diagnosis and the resulting bladder and sphincter dysfunction. This narrative review is designed to address the question regarding which NLUTD population benefits most from pelvic floor therapy and behavioral interventions, and ...
Sara M. Lenherr
wiley   +1 more source

Prevalence of Anal Incontinence and Constipation in Female Patients with Urinary Incontinence

Journal of Urological Surgery, 2018
Objective: To investigate the prevalence of anal incontinence and constipation in patients with urinary incontinence. Materials and Methods: Adult female patients who presented with the complaint of urinary incontinence were evaluated with anal ...
Musa Saraçoğlu, Aşkın Eroğlu, Rauf Taner Divrik   +2 more
doaj   +1 more source

Trends and Racial/Ethnic Disparities in Pharmacologic and Surgical Management of Treated Female Patients With Urinary Incontinence

Neurourology and Urodynamics, EarlyView.
ABSTRACT Background The current literature summarizes the trends in the surgical management of stress urinary incontinence (SUI) and not the general trends of management for all UI types in the US. Additionally, recent evidence on racial and ethnic disparities in UI related surgical utilization is limited. Objective To describe the currently prescribed
Rawan O. Almadfaa, Patricia R. Wigle, Alex C. Lin, Angelica Hardee, Jeff J. Guo, Ana L. Hincapie   +5 more
wiley   +1 more source